share_log

Prosus (OTCMKTS:PROSY) Vs. Sysmex (OTCMKTS:SSMXY) Head to Head Review

Prosus (OTCMKTS:PROSY) Vs. Sysmex (OTCMKTS:SSMXY) Head to Head Review

Prosus (OTCMKTS: PROSY) vs.Sysmex (OTCMKTS: SSMXY) 頭對頭審查
Defense World ·  2023/04/08 01:31

Prosus (OTCMKTS:PROSY – Get Rating) and Sysmex (OTCMKTS:SSMXY – Get Rating) are both large-cap retail/wholesale companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings.

Prosus(OTCMKTS: PROSY — 獲取評級)和 Sysmex(OTCMKTS: SSMXY — 獲取評級)都是大型零售/批發公司,但哪家企業更好?我們將根據兩家公司的風險實力、估值、分析師建議、機構所有權、盈利能力、股息和收益進行比較。

Profitability

盈利能力

This table compares Prosus and Sysmex's net margins, return on equity and return on assets.

該表比較了Prosus和Sysmex的淨利潤率、股本回報率和資產回報率。

Get
獲取
Prosus
Prosus
alerts:
警報:
Net Margins Return on Equity Return on Assets
Prosus N/A N/A N/A
Sysmex 11.70% 12.51% 9.11%
淨利潤 股本回報率 資產回報率
Prosus 不適用 不適用 不適用
Sysmex 11.70% 12.51% 9.11%

Volatility and Risk

波動性和風險

Prosus has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, Sysmex has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500.

Prosus的beta值爲0.58,這意味着其股價的波動性比標準普爾500指數低42%。相比之下,Sysmex的beta值爲0.71,這意味着其股價的波動性比標準普爾500指數低29%。

Valuation and Earnings

估值和收益

This table compares Prosus and Sysmex's gross revenue, earnings per share (EPS) and valuation.

該表比較了Prosus和Sysmex的總收入、每股收益(EPS)和估值。

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Prosus $6.87 billion 35.04 $18.73 billion N/A N/A
Sysmex $3.24 billion 4.28 $392.42 million $0.88 37.61
總收入 價格/銷售比率 淨收入 每股收益 市盈率
Prosus 68.7 億美元 35.04 187.3 億美元 不適用 不適用
Sysmex 32.4 億美元 4.28 3.9242 億美元 0.88 美元 37.61

Prosus has higher revenue and earnings than Sysmex.

Prosus 的收入和收益高於 Sysmex。

Analyst Ratings

分析師評級

This is a breakdown of recent ratings and recommmendations for Prosus and Sysmex, as reported by MarketBeat.com.

這是Marketbeat.com報道的Prosus和Sysmex最近評級和推薦的明細。

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prosus 0 2 5 0 2.71
Sysmex 0 1 0 0 2.00
賣出評級 保持收視率 買入評級 強勁的買入評級 評分分數
Prosus 0 2 5 0 2.71
Sysmex 0 1 0 0 2.00

Prosus presently has a consensus price target of $87.85, suggesting a potential upside of 472.69%. Given Prosus' stronger consensus rating and higher possible upside, research analysts plainly believe Prosus is more favorable than Sysmex.

Prosus目前的共識目標價爲87.85美元,表明潛在的上漲空間爲472.69%。鑑於Prosus更強的共識評級和更高的可能上行空間,研究分析師顯然認爲Prosus比Sysmex更有利。

Institutional and Insider Ownership

機構所有權和內部所有權

0.0% of Prosus shares are held by institutional investors. 0.5% of Prosus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

0.0%的Prosus股票由機構投資者持有。0.5%的Prosus股票由內部人士持有。強大的機構所有權表明對沖基金、大型基金經理和捐贈機構認爲股票有望實現長期增長。

Summary

摘要

Prosus beats Sysmex on 8 of the 12 factors compared between the two stocks.

在兩隻股票比較的12個因素中,Prosus在8個因素上擊敗了Sysmex。

About Prosus

關於 Prosus

(Get Rating)

(獲取評分)

Prosus N.V. engages in the e-commerce and internet businesses. The company operates internet platforms, such as classifieds, payments and fintech, food delivery, travel, education technology, etail, health, ventures, social, and other internet platforms. It has operations in Latin and North America, the Middle East, Africa, Europe, Asia, and internationally. The company was formerly known as Myriad International Holdings N.V. and changed its name to Prosus N.V. in August 2019. Prosus N.V. was incorporated in 1994 and is headquartered in Amsterdam, the Netherlands. Prosus N.V. is a subsidiary of Naspers Limited.

Prosus N.V. 從事電子商務和互聯網業務。該公司運營互聯網平臺,例如分類廣告、支付和金融科技、送餐、旅行、教育技術、零售、健康、風險投資、社交和其他互聯網平臺。它在拉丁美洲和北美、中東、非洲、歐洲、亞洲和國際上開展業務。該公司前身爲Myriad International Holdings N.V.,並於2019年8月更名爲Prosus N.V.。Prosus N.V. 成立於 1994 年,總部位於荷蘭阿姆斯特丹。Prosus N.V. 是 Naspers Limited 的子公司。

About Sysmex

關於 Sysmex

(Get Rating)

(獲取評分)

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

Sysmex Corp. 從事醫療保健業務。它開發、製造、銷售、出口和進口用於體外診斷的診斷儀器、試劑和軟件。它還提供血液、尿液和其他樣本的臨牀實驗室檢測。其產品包括用於止血、免疫化學、臨牀化學、尿液分析和即時 (POC) 測試的診斷儀器和試劑。它通過以下地理區域運營:日本、美洲、歐洲、中東和非洲 (EMEA)、中國和亞太地區。該公司由中谷太郎於1968年2月20日創立,總部位於日本神戶。

Receive News & Ratings for Prosus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prosus and related companies with MarketBeat.com's FREE daily email newsletter.

接收 Prosus Daily 的新聞和收視率 -在下面輸入您的電子郵件地址,以通過Marketbeat.com的免費每日電子郵件時事通訊接收Prosus及相關公司最新新聞和分析師評級的簡明每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論